FDA Approved: ELITEK — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for ELITEK (rasburicase) submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor Lysis Syndrome

Drugs mentioned

• ELITEK (rasburicase)

Snippet

SUPPL AP for ELITEK (RASBURICASE)